C. Fausel

发表

Comparison of an assumption‐free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing

Seza Orcun, Gintaras V Reklaitis, G. Reklaitis, 2014, Pharmacotherapy.

Validation of a Novel Approach for Dose Individualization in Pharmacotherapy Using Gabapentin in a Proof of Principles Study

Seza Orcun, G. Reklaitis, E. Anaissie, 2013, Pharmacotherapy.

Targeted Chronic Myeloid Leukemia Therapy: Seeking a Cure

C. Fausel, 2007, Journal of managed care pharmacy : JMCP.

Enhancing the Budget Impact Model for Institutional Use: A Tool with Practical Applications for the Hospital Oncology Pharmacy

R. Klein, S. Perk, C. Fausel, 2016, Hospital pharmacy.

Safe Handling of Hazardous Drugs: ASCO Standards.

T. Oliver, R. Zon, P. Celano, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Desensitization to imatinib in patients with leukemia.

K. Cornetta, R. Nelson, L. Cripe, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia

C. Fausel, D. Frame, J. Sessions, 2007, Journal of managed care pharmacy : JMCP.

Targeted chronic myeloid leukemia therapy: Seeking a cure.

C. Fausel, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier on

Cynthia S. Johnson, L. Einhorn, J. Picus, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Iron overload in myelodysplastic syndromes. Introduction.

R. Harvey, C. Fausel, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Iron chelation therapy in myelodysplastic syndromes.

C. Fausel, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Novel treatment strategies for chronic myeloid leukemia.

C. Fausel, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Thrombotic thrombocytopenic purpura and simvastatin

P. Porcu, C. Sweeney, C. Danielson, 1998, The Lancet.

Recurring Chemotherapy‐Associated Alopecia Areata: Case Report and Literature Review

C. Fausel, S. Motl, 2003, Pharmacotherapy.

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia

K. Cornetta, R. Hromas, G. Vance, 2010, Bone Marrow Transplantation.

Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.

K. Cornetta, R. Nelson, S. Farag, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Central nervous system infections due to Stomatococcus mucilaginosus in immunocompromised hosts.

M. Goldman, C. Fausel, A. Greist, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Retrospective Record Review of Mobilization Strategies with and without Plerixafor for Autologous Stem Cell Transplant in Patients with Multiple Myeloma

E. Drea, J. Bubalo, Y. Barnes, 2019, Blood.

Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21.

C. Yiannoutsos, L. Cripe, R. Abonour, 2007, The oncologist.

Observations of second primary malignancy in patients with multiple myeloma.

R. Abonour, C. Fausel, P. Kiel, 2012, Clinical lymphoma, myeloma & leukemia.

Effect of fat emulsion and supersaturation on calcium phosphate solubility in parenteral nutrient admixtures.

D. W. Newton, D. Driscoll, L. Allen, 1997, International journal of pharmaceutical compounding.

Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures

D. W. Newton, D. Driscoll, L. Allen, 1997 .

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study

Cynthia S. Johnson, N. Hanna, L. Einhorn, 2016, Supportive Care in Cancer.

Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.

K. Sowinski, B. Overholser, C. Fausel, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia

C. Fausel, D. Frame, J. Sessions, 2007, Journal of Managed Care Pharmacy.

Phase II study of fosaprepitant +5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: A Hoosier Cancer Research Network Study.

N. Hanna, L. Einhorn, C. Fausel, 2015 .

Targeted chronic myeloid leukemia therapy: Seeking a cure.

C. Fausel, 2007, American Journal of Health-System Pharmacy.